FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 111 filers reported holding FULCRUM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $419,000 | – | 23,708 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $93,706,000 | 25.43% |
| TRV GP IV, LLC | 2,343,154 | $55,416,000 | 20.30% |
| COWEN AND COMPANY, LLC | 3,453,371 | $81,672,000 | 7.86% |
| Logos Global Management LP | 1,000,000 | $23,650,000 | 3.07% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $4,730,000 | 2.21% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,613,412 | $61,807,000 | 1.89% |
| RTW INVESTMENTS, LP | 3,611,194 | $85,405,000 | 1.77% |
| Monashee Investment Management LLC | 236,991 | $5,600,000 | 1.62% |
| Paradigm Biocapital Advisors LP | 212,961 | $5,037,000 | 1.33% |
| Parkman Healthcare Partners LLC | 164,453 | $3,889,000 | 1.14% |